Iceland vs Slovenia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Iceland
0.0%
in 2024
Slovenia
0.0%
in 2024
Iceland rank
167th
Slovenia rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Iceland
- Slovenia
How they compare
Iceland currently reports 0.0% against 0.0% in Slovenia, a difference of 0.0%.
Across all 10 years both countries report, Slovenia has been ahead every year.
Iceland ranks 167th and Slovenia ranks 167th of 246 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.2% | 0.1% | Slovenia |
| 2020s | 0.0% | 0.1% | 0.1% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Iceland or Slovenia?
- Iceland, at 0.0% against 0.0% in Slovenia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Iceland and Slovenia?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Slovenia?
- 10 years are reported by both, from 2015 to 2024.
- How do Iceland and Slovenia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Iceland ranks 167th and Slovenia ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.